GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.3 MXN | +3.16% |
|
+8.23% | +15.11% |
Presenter SpeechUnknown Executive (Executives)Hello, everybody. I'm [ Damian ] [indiscernible]...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Companyâs product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.
Sector
Pharmaceuticals
Calendar
2024-04-27
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
16.3
MXN
Average target price
21.03
MXN
Spread / Average Target
+29.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.11% | 882M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- LAB B Stock
- News Genomma Lab Internacional, S.A.B. de C.V.
- Transcript : Genomma Lab Internacional, S.A.B. de C.V. - Analyst/Investor Day
